Dovato (dolutegravir/lamivudine) is a brand-name oral tablet used for treating HIV in certain adults and children. Dovato has interactions with some drugs and ...

GSK has fired a shot across the bows of Gilead Sciences' HIV juggernaut Biktarvy, with new data showing its rival therapy Dovato is as effective but causes less weight gain. The results of the ...

The new regimen, dubbed Dovato, is approved in adults and adolescents above 12 years of age with HIV-1, and is based on a combination of dolutegravir and lamivudine given as a single pill once daily.

ViiV Healthcare, a global company specialising in human immunodeficiency virus (HIV), has announced the availability of Dovato in a new blister pack format in the US. Dovato is a once-daily ...

A show at the Grey Art Museum re-establishes Berthe Weill as a guiding light of the Parisian avant-garde. Her rediscovery has been led by women. By Hilarie M. Sheets The German artist Thomas ...

The combination of dolutegravir and lamivudine has been approved as a two-drug pill, marketed under the name Dovato. See Dovato for details of studies that led to its approval and further information ...